Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura
- PMID: 15953274
- DOI: 10.1111/j.1526-4610.2005.05109.x
Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura
Abstract
Objectives: To assess headache-related disability in chronic migraine with medication overuse (CMO), as defined by Silberstein and Lipton (1996, 2001) in comparison to that caused by migraine without aura, investigating similarities and differences in disability patterns in these two conditions.
Background: It is well known that migraine has a marked impact on daily activities. Less information is available on the functional consequences of chronic migraine.
Methods: This was a prospective study on 247 patients with CMO and 264 with migraine without aura. All completed the validated Italian version of the Migraine Disability Assessment questionnaire (MIDAS). The MIDAS total score and scores of each question (investigating total or partial inability to perform different daily activities) were evaluated, and compared in the two groups using the Mann-Whitney rank sum test. We also evaluated the number of missed days (question 1) and days with significantly reduced effectiveness at work (question 2) and in nonwork activities (questions 3, 4, and 5), using descriptive statistics.
Results: MIDAS total score in the CMO group was rather high (mean 84.1, median 70) and significantly higher than in the migraine group (mean 23.4, median 19). CMO patients also reported higher scores than migraine patients in MIDAS questions investigating disability in different domains, the differences being highly significant for questions 3, 4, and 5. In both CMO and migraine the number of days with total or significant disability in nonwork activities was higher than the number of days with total or significant disability in work activities, and days spent at work with significantly reduced effectiveness were more than work days missed.
Conclusions: Our findings show that CMO has a profound effect on patients' daily functioning. They suggest that differences between CMO and migraine are mainly quantitative, while the two groups are similar in terms of disability pattern. These results are consistent with the fact that CMO may be an evolution of episodic migraine, characterized by increase in headache frequency and more evident disability in performing different daily duties.
Similar articles
-
Disability and quality of life in different primary headaches: results from Italian studies.Neurol Sci. 2004 Oct;25 Suppl 3:S105-7. doi: 10.1007/s10072-004-0263-y. Neurol Sci. 2004. PMID: 15549514
-
Chronic migraine with medication overuse: treatment outcome and disability at 3 years follow-up.Neurol Sci. 2004 Oct;25 Suppl 3:S272-3. doi: 10.1007/s10072-004-0306-4. Neurol Sci. 2004. PMID: 15549557
-
Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up.Headache. 2004 Jul-Aug;44(7):678-83. doi: 10.1111/j.1526-4610.2004.04127.x. Headache. 2004. PMID: 15209690
-
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability.Neurology. 2001;56(6 Suppl 1):S20-8. doi: 10.1212/wnl.56.suppl_1.s20. Neurology. 2001. PMID: 11294956 Review.
-
[Evidence 1: diagnostic management of migraine headache and evaluation of disability in adults and children].Rev Neurol (Paris). 2003 Jul;159(6-7 Pt 2):S22-45. Rev Neurol (Paris). 2003. PMID: 12928617 Review. French. No abstract available.
Cited by
-
Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy.Neurol Sci. 2008 May;29 Suppl 1:S176-8. doi: 10.1007/s10072-008-0918-1. Neurol Sci. 2008. PMID: 18545928 Clinical Trial.
-
Prophylaxis of migraine: general principles and patient acceptance.Neuropsychiatr Dis Treat. 2008 Dec;4(6):1155-67. doi: 10.2147/ndt.s3497. Neuropsychiatr Dis Treat. 2008. PMID: 19337456 Free PMC article.
-
Validation of criterion-based patient assignment and treatment effectiveness of a multidisciplinary modularized managed care program for headache.J Headache Pain. 2012 Jul;13(5):379-87. doi: 10.1007/s10194-012-0453-6. Epub 2012 May 13. J Headache Pain. 2012. PMID: 22581187 Free PMC article.
-
Economic impact of a triptan Rx-to-OTC switch in six EU countries.PLoS One. 2013 Dec 19;8(12):e84088. doi: 10.1371/journal.pone.0084088. eCollection 2013. PLoS One. 2013. PMID: 24367628 Free PMC article.
-
Disability and quality of life in patients with different forms of migraine.J Headache Pain. 2015 Dec;16(Suppl 1):A4. doi: 10.1186/1129-2377-16-S1-A4. J Headache Pain. 2015. PMID: 28132384 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous